Skip to content

NEWPHARMA

Active
Public limited companyfounded 2011active for 15 yearsRue Basse-Wez 315/317, 4020 Liège, BelgiumKBO/BCE: BE 0838.666.156
Summary

NEWPHARMA has been active since 2011 and the Belgian Official Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €1.8m and a net result of -€711,789. Equity is growing by about 8.3% per year across the filed financial years. Its solvency ranks better than 15% of 332 sector peers (NACE 47, financial year 2026). The computed 12-month bankruptcy probability is 0.7% (low).

Risk analysisFollow ReportCompare
NEWPHARMAActiveChecked score 68/100
Risk analysis ReportCompare

History

NEWPHARMA was incorporated on 22 August 2011.1 Turnover grew from €81.8m in 2018 to €218.2m in 2026 and headcount from 6.8 to 14.3 full-time equivalents.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018 and 2026

Acts, filings and financial milestones

Next filing, financial year 2027, expected by 31-10-2027
2026
21-09
NBB filing Annual accounts filed
financial year 2026 · full format
2025
25-09
NBB filing Annual accounts filed
financial year 2025 · full format
31-03
Financial Back to profitnet €273,324
Net result €273,324 after 5 loss-making years.
2024
21-11
Gazette deed Capital & shares · Amendment of the articles · Legal-form change
Auditor report · Legal-form conversion · Capital9 facts ▸
  • Other provision, “dispense de lecture des rapports, Monsieur le Président” (deed in French)
  • Auditor report, “demandes d’informations,procédures analytiques et autres procédures d’évaluation,étendue considérablement inférieure à un contrôle,aucune opinion d’audit,élémen…” (deed in French)
  • Other provision, “réception des rapports par les actionnaires, copie des rapports et de l’état résumant la situation active et passive” (deed in French)
  • Other provision, “annexe et dépôt des rapports, copie de chaque rapport restera ci-annexé” (deed in French)
  • Legal-form conversion, “Société Anonyme” (deed in French)
  • Amendment of the articles
  • Capital, €5,050,000
  • Other provision, “coordination des statuts, assurer dépôt au dossier société” (deed in French)
  • Power of attorney
19-09
NBB filing Annual accounts filed
financial year 2024 · unclassified schema
17-01
Gazette deed Appointments: CASTELEIN, Kris Roger, GOETHAERT, Stefan Annie Willy Maria and 2 others
Legal form clause · Capital conversion · Amendment of the articles13 facts ▸
  • General meeting, 09:30, “tiendra” (deed in French)
  • Legal form clause, “adapter et conserver, société à responsabilité limitée” (deed in French)
  • Capital conversion, “compte de capitaux propres statutairement indisponible” (deed in French)
  • Capital conversion, “supprimer, fonds disponibles pour distribution” (deed in French)
  • Amendment of the articles
  • Power of attorney, Willem Muyshondt
  • Power of attorney, Hendrik MUYSHONDT
  • Director appointment, CASTELEIN, Kris Roger (director)
  • Director appointment, GOETHAERT, Stefan Annie Willy Maria (director)
  • Director appointment, VANDAMME, Stefaan Walter Alphons (director)
  • Director appointment, WILLEMYNS, Jo Paul Maria Agnès Maurits (director)
  • Other provision, “décharge au gérant démissionnaire, prochaine assemblée générale annuelle” (deed in French)
  • +1 further fact in this act
2023
20-10
Gazette deed Appointment: EY Réviseurs d'Entreprises (commissaire aux comptes)
Permanent representative: Jourquin Gilles4 facts ▸
  • Auditor appointment, EY Réviseurs d'Entreprises (commissaire aux comptes)
  • Other provision, “acceptation du mandat et incompatibilités, aucune des incompatibilités prévues par les dispositions légales en vigueur” (deed in French)
  • Permanent representative, Jourquin Gilles
  • Director in office, GJ Lifesciences Management SRL (managing director)
05-07
NBB filing Annual accounts filed
financial year 2022 · unclassified schema
09-01
Gazette deed Capital & shares · Legal-form change
Capital contribution · Bank account6 facts ▸
  • General meeting, 26-12-2022
  • Capital contribution, €5,000,000
  • Other provision, “sans émission de nouvelles actions” (deed in French)
  • Other provision, “absence de rapports d’émission, article 5:120,§2 du Code des sociétés et des associations” (deed in French)
  • Bank account, “article 5:132 du Code des sociétés et des associations, compte spécial au nom de la Société” (deed in French)
  • Other provision, “extrait délivré avant enregistrement, article 173,1°bis du Code des Droits d'Enregistrement” (deed in French)
2022
31-12
Financial Equity above €2mequity €2.5m
Equity rises from -€1.1m to €2.5m.
06-07
NBB filing Annual accounts filed
financial year 2021 · unclassified schema
2021
28-07
NBB filing Annual accounts filed
financial year 2020 · unclassified schema
Show earlier events
2020
31-12
Financial Weakest financial yearnet -€1.8m
Net result drops to -€1.8m, the lowest in the series; recovery starts the following year.
14-08
NBB filing Annual accounts filed
financial year 2019 · full format · 14 days late
2019
25-07
NBB filing Annual accounts filed
financial year 2018 · full format
2018
10-07
NBB filing Annual accounts filed
financial year 2017 · full format
2017
25-07
NBB filing Annual accounts filed
financial year 2016 · full format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 15 annual accounts filed, the latest 10 are here; all 15 are under Financials.
4 of 12 deeds read
About the unread acts

Of the 12 Belgian Official Gazette deeds we know for this company, 4 have been read. The other 8 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

We would like to set cookies. That happens only with your consent. What we measure